Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil

• Autor(a) principal: Penetra, Stephanie L. S.
• Data de Publicação: 2021
• Outros Autores: Silva, Michele F. B. da, Resende, Paola, Pina-Costa, Anielle, Santos, Heloisa F. P., Guaraldo, Lusiele, Calvet, Guilherme A., Ogrzewalska, Maria, Arantes, Ighor, Zukeram, Ketiuce, Araújo, Mia F. de, Lima, Ana Beatriz Machado, Lopes, Renata Serrano, Lira-Silva, Larissa R., Moraes, Isabella V., Wakimoto, Mayumi D., Fuller, Trevon L., Gabaglia, Claudia Raja, Espíndola, Otávio M., Bonaldo, Myrna C., Daniel-Ribeiro, Cláudio Tadeu, Whitworth, Jimmy, Smith, Chris, Nielsen-Saines, Karin, Pauvolid-Correa, Alex, Siqueira, Marilda Agudo Mendonça Teixeira de, Brasil, Patricia
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
• Texto Completo: https://www.arca.fiocruz.br/handle/icict/50470
• topic: COVID-19; SARS-CoV-2 variants; Health personnel; Post-acute syndrome; Reinfection; Whole-genome sequencing; Breakthrough infection

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.